FMC vs PPCB · rev $1.22B vs P/E 0.0, $3.9M cap
FMC Corporation (FMC) versus Propanc Biopharma, Inc. Common Stock (PPCB) — a side-by-side from cached financials, not a winner call.
FMC Corporation (FMC) is a agricultural inputs company listed on NYSE.
Propanc Biopharma, Inc. Common Stock (PPCB) is a biotechnology company listed on NASDAQ.
Latest reported FMC revenue for 2024-12-31 was $1.22B. Net income was -$16.1M. Revenue was up 14.9% from 2024-09-30 to 2024-12-31. FMC currently screens at market cap $1.50B.
PPCB does not have a complete income-statement cache yet.
FMC currently screens at market cap $1.50B. PPCB currently screens at market cap $3.9M and trailing P/E 0.0.
Not investment advice. Open the FMC and PPCB stock pages for the full models.
Not investment advice.